AI use case

AI Drug Discovery - 30-Day Cycle vs Years

Pfizer has fundamentally transformed its pharmaceutical operations through AI, cutting drug discovery timelines from years to 30 days and saving 16,000 hours annually in researc…

Browse catalog

At a glance

Core facts from this catalog record. Primary narrative lives in the hero above; full raw fields follow in the next section.

Company/Organization: Pfizer
Industry: Biotechnology
Location: New York

Record fields

Every column from the source row, in stable order. URLs open in a new tab.

Title

AI Drug Discovery - 30-Day Cycle vs Years

Content

Pfizer has fundamentally transformed its pharmaceutical operations through AI, cutting drug discovery timelines from years to 30 days and saving 16,000 hours annually in research alone. The company uses AWS for generative AI across manufacturing and research, with Anthropic Claude enabling natural language searches across vast datasets that cut search time by 80%. In manufacturing, AI boosts product yield by 10%, reduces cycle time by 25%, and increases throughput by 20%. Pfizer partnered with Flagship Pioneering leveraging the AI-powered Logica platform for autoimmune disease molecule discovery. In clinical trials, AI helped accelerate Paxlovid development for COVID-19 through virtual screening and AI-powered molecular analysis. AI also automates production of regulatory documents and anticipates questions from government agencies, saving weeks in the regulatory process. The company operates the Pfizer-Amazon Collaboration Team (PACT) which prototypes AI solutions in six-week cycles, down from traditional months-long development cycles. AI is further deployed in supply chain management for predictive maintenance and shortage forecasting.

URL

https://chiefaiofficer.com/how-pfizer-cut-drug-discovery-time-from-years-to-30-days-and-what-every-ceo-can-learn/

Continue exploring AI deployments in the catalog.

Back to use cases